CD53 and metabolic dysfunction-associated steatotic liver disease: Additionally, it has been shown that SRGN, CD53, NCKAP1L, LCP1, EVI2B, MPEG1 and TYROBP may be potential pathological target gene for NAFLD and NASH, which is highly similar to our Turquoise module (58).